CSI Market
Sign In | Register

Alterola Biotech Inc (ALTA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ALTA Annual Balance Sheets →
From Alterola Biotech Inc through Sep 30 2023, shifts in Sep 30 2024's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent0.08
Cash & Short-term Investments0.00
Inventories0.00
Deferred Offering Costs DE0.00
Other Current Assets1.06
Total Current Assets1.15
Deferred Costs, Noncurrent AS0.16
Other Assets, Noncurrent0.06
Loans Receivable Current Amount1.06
Total Assets1.36
Liabilities
Accounts Payable, Current AC0.81
Accrued Liabilities, Current AC0.46
Loans Payable, Current NO0.19
Other Liabilities, Current2.15
Total Current Liabilities3.62
Long-term debt1.84
Total Long-term Debt1.84
Total Liabilities3.62
Stockholders' Equity
Treasury Stock Common Value-
Common Stock Value1.47
Additional Paid In Capital Common Stock10.23
Retained Earnings / Accumulated Deficit-13.67
Other Equity-0.08
Common Stockholder's Equity-2.05
Non-controlling interests & other-0.20
Total Stockholder's Equity-2.25
Liabilities & Stockholder's Equity1.36
4 historic quarters locked

Sign in to unlock the full Alterola Biotech Inc balance sheet history.

Sign In Create Free Account

About Alterola Biotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 27, 2024
  • Source: abti_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-24-007731

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.